Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imaging on Lung Cancer and Treatment with Targeted Therapy.

Seminars in ultrasound, CT, and MR - 1 Jun 2018

Shroff Girish S, Benveniste Marcelo F, de Groot Patricia M, Carter Brett W, Wu Carol C, Viswanathan Chitra, Truong Mylene T

Abstract excerpt

The identification of genetic mutations known as oncogenic driver mutations that lead to the growth and survival of cancer cells has been an important advance in the field of oncology. Treatment in advanced non-small-cell lung cancer (NSCLC) has transitioned from a more general approach to a more personalized approach based on genetic mutations of the cancer itself. Common mutations detected in patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Antineoplastic Agents, Immunological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arginine Vasopressin

Share to Bevacizumab

Share to Crizotinib

Share to Erlotinib Hydrochloride

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 29807641
DOI: 10.1053/j.sult.2018.02.003

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imaging on Lung Cancer and Treatment with Targeted Therapy.PMID 29807641Read ↗

Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesionsSemantic proximity Read ↗

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.Semantic proximity Read ↗

Evaluation and treatment of patients with non-small cell lung cancer.Semantic proximity Read ↗

[Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer].Semantic proximity Read ↗

ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.Semantic proximity Read ↗

Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.Semantic proximity Read ↗

Confronting synchronous multiple primary lung cancers: Navigating the intersection of challenges and opportunities.Semantic proximity Read ↗

Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.Semantic proximity Read ↗

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?Semantic proximity Read ↗

Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer.Semantic proximity Read ↗

New targets and new mechanisms in lung cancer.Semantic proximity Read ↗

ALK positivity on pleuroscopic pleural biopsy in lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.